Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Inthorn

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Zentralblatt Fur Chirurgie|December 24, 2004
[Economic aspects of intensive care medicine--cost and reimbursement according to diagnosis related grouping]A Billing, M Thalhammer, H-J Eissner, et al.
Progress in Clinical and Biological Research|January 1, 1987
Quantification of granulocyte enzymes/proteins with immunoassaysH Lang, S Neumann, W Rautenberg, et al.
Shock (Augusta, Ga.)|November 25, 2000
The thrombin antagonist hirudin fails to inhibit endotoxin-induced leukocyte/endothelial cell interaction and microvascular perfusion failureJ N Hoffmann, B Vollmar, D Inthorn, et al.
Shock (Augusta, Ga.)|November 24, 1999
A chronic model for intravital microscopic study of microcirculatory disorders and leukocyte/endothelial cell interaction during normotensive endotoxemiaJ N Hoffmann, B Vollmar, D Inthorn, et al.
Zentralblatt Fur Chirurgie|January 1, 1995
[Postoperative infusion therapy: electrolyte solution in comparison with hypocaloric glucose and carbohydrate exchange-amino acid solutions]K W Jauch, G Kröner, A Hermann, et al.
American Journal of Physiology. Cell Physiology|July 18, 2000
Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathwayJ N Hoffmann, B Vollmar, D Inthorn, et al.
Behring Institute Mitteilungen|February 1, 1986
Pathobiochemistry of sepsis: role of proteinases, proteinase inhibitors and oxidizing agentsM Jochum, J White, K H Duswald, et al.
Kidney International|November 1, 1995
Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substancesJ N Hoffmann, W H Hartl, R Deppisch, et al.
Intensive Care Medicine|December 1, 1996
Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsisJ N Hoffmann, W H Hartl, R Deppisch, et al.
Shock (Augusta, Ga.)|September 15, 1999
Hemofiltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compoundsJ N Hoffmann, K Werdan, W H Hartl, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Zentralblatt Fur Chirurgie|December 24, 2004
[Economic aspects of intensive care medicine--cost and reimbursement according to diagnosis related grouping]A Billing, M Thalhammer, H-J Eissner, et al.
Progress in Clinical and Biological Research|January 1, 1987
Quantification of granulocyte enzymes/proteins with immunoassaysH Lang, S Neumann, W Rautenberg, et al.
Shock (Augusta, Ga.)|November 25, 2000
The thrombin antagonist hirudin fails to inhibit endotoxin-induced leukocyte/endothelial cell interaction and microvascular perfusion failureJ N Hoffmann, B Vollmar, D Inthorn, et al.
Shock (Augusta, Ga.)|November 24, 1999
A chronic model for intravital microscopic study of microcirculatory disorders and leukocyte/endothelial cell interaction during normotensive endotoxemiaJ N Hoffmann, B Vollmar, D Inthorn, et al.
Zentralblatt Fur Chirurgie|January 1, 1995
[Postoperative infusion therapy: electrolyte solution in comparison with hypocaloric glucose and carbohydrate exchange-amino acid solutions]K W Jauch, G Kröner, A Hermann, et al.
American Journal of Physiology. Cell Physiology|July 18, 2000
Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathwayJ N Hoffmann, B Vollmar, D Inthorn, et al.
Behring Institute Mitteilungen|February 1, 1986
Pathobiochemistry of sepsis: role of proteinases, proteinase inhibitors and oxidizing agentsM Jochum, J White, K H Duswald, et al.
Kidney International|November 1, 1995
Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substancesJ N Hoffmann, W H Hartl, R Deppisch, et al.
Intensive Care Medicine|December 1, 1996
Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsisJ N Hoffmann, W H Hartl, R Deppisch, et al.
Shock (Augusta, Ga.)|September 15, 1999
Hemofiltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compoundsJ N Hoffmann, K Werdan, W H Hartl, et al.
Pageof 6